Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body composition von Bunck, Mathijs C, Diamant, Michaela, Eliasson, Bjorn, Cornér, Anja, Shaginian, Rimma M, Heine, Robert J, Taskinen, Marja-Riitta, Yki-Järvinen, Hannele, Smith, Ulf

Volltext

Effects of Exenatide on Measures of β-Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes von Bunck, Mathijs C, Cornér, Anja, Eliasson, Bjorn, Heine, Robert J, Shaginian, Rimma M, Taskinen, Marja-Riitta, Smith, Ulf, Yki-Järvinen, Hannele, Diamant, Michaela

Volltext

One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients: A randomized, controlled trial von Bunck, Mathijs C, Diamant, Michaela, Cornér, Anja, Eliasson, Bjorn, Malloy, Jaret L, Shaginian, Rimma M, Deng, Wei, Kendall, David M, Taskinen, Marja-Riitta, Smith, Ulf, Yki-Järvinen, Hannele, Heine, Robert J

Volltext

One-year treatment with exenatide vs. Insulin Glargine: Effects on postprandial glycemia, lipid profiles, and oxidative stress von Bunck, Mathijs C, Cornér, Anja, Eliasson, Bjorn, Heine, Robert J, Shaginian, Rimma M, Wu, Yan, Yan, Ping, Smith, Ulf, Yki-Järvinen, Hannele, Diamant, Michaela, Taskinen, Marja-Riitta

Volltext

Accuracy Beyond ISO: Introducing a New Method for Distinguishing Differences Between Blood Glucose Monitoring Systems Meeting ISO 15197:2013 Accuracy Requirements von Pardo, Scott, Shaginian, Rimma M., Simmons, David A.

Volltext

One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients von Mathijs C. Bunck, Michaela Diamant, Anja Cornér, Bjorn Eliasson, Jaret L. Malloy, Rimma M. Shaginian, Wei Deng, David M. Kendall, Marja-Riitta Taskinen, Ulf Smith, Hannele Yki-Järvinen, Robert J. Heine

Volltext

Effects of Exenatide on Measures of [Beta]-Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes von Bunck, Mathijs C, Cornér, Anja, Eliasson, Bjorn, Heine, Robert J, Shaginian, Rimma M, Taskinen, Marja-Riitta, Smith, Ulf, Yki-Järvinen, Hannele, Diamant, Michaela

Volltext

One-Year Treatment With Exenatide Improves ß-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients: A randomized, controlled trial von Bunck, Mathijs C, Diamant, Michaela, Cornér, Anja, Eliasson, Bjorn, Malloy, Jaret L, Shaginian, Rimma M, Deng, Wei, Kendall, David M, Taskinen, Marja-Riitta, Smith, Ulf, Yki-Järvinen, Hannele, Heine, Robert J

Volltext

2181-PUB: The Patient Characteristics of Contour Diabetes App Users Worldwide von RICHARDSON, JAMES M., PARDO, SCOTT, SHAGINIAN, RIMMA

Volltext